Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Health Affairs (Project Hope)|January 1, 1996
Do open formularies increase access to clinically useful drugs?B L Walser, D Ross-Degnan, S B SoumeraiThe Milbank Quarterly|January 1, 1997
Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?S B Soumerai, D Ross-Degnan, E E Fortess, et al.The New England Journal of Medicine|March 4, 1999
Inadequate prescription-drug coverage for Medicare enrollees--a call to actionS B Soumerai, D Ross-DegnanThe Milbank Quarterly|January 1, 1992
Effects of professional and media warnings about the association between aspirin use in children and Reye's syndromeS B Soumerai, D Ross-Degnan, J S KahnHealth Affairs (Project Hope)|February 24, 2001
Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?A S Adams, S B Soumerai, D Ross-DegnanAnnual Review of Public Health|March 29, 2001
The case for a medicare drug coverage benefit: a critical review of the empirical evidenceA S Adams, S B Soumerai, D Ross-DegnanJAMA|February 9, 1990
Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experimentS B Soumerai, D Ross-Degnan, S Gortmaker, et al.The New England Journal of Medicine|August 27, 1987
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equityS B Soumerai, J Avorn, D Ross-Degnan, et al.International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 6, 1999
Evidence of self-report bias in assessing adherence to guidelinesA S Adams, S B Soumerai, J Lomas, et al.The Joint Commission Journal on Quality Improvement|August 2, 2001
Designing an intervention to improve the management of Helicobacter pylori infectionS R Majumdar, S B Soumerai, M Lee, et al.Pageof 11